Get started
Author

Firas Hatoum

Observed institution: Moffitt Cancer Center
ORCID: 0009-0007-5293-6176
Observed ORCID: 0009-0007-5293-6176
OpenAlex ID: A5115949070
Immune-Based and Novel Therapies in Variant Histology Renal Cell Carcinomas
2025 · Justin W. Miller, Jeffrey S. Johnson, et al. · Cancers · 9
PDF
Phase 2 study of dostarlimab plus niraparib in stage III-IV recurrent or refractory Penile squamous cell carcinoma
2025 · Firas Hatoum, Gabriel Roman Souza, et al. · Future Oncology · 4
Current Role and Future Frontiers of Spatial Transcriptomics in Genitourinary Cancers
2025 · Firas Hatoum, Adnan Fazili, et al. · Cancers · 3
PDF
Multidisciplinary Care of Patients With Penile Cancer
2026 · Luis G. Medina, Firas Hatoum, et al. · American Society of Clinical Oncology Educational Book · 1
PDF
Geospatial and Cell Density Analysis Using Multiplex Immunofluorescence Reveals an Important Role of Clustering Patterns of Immunosuppressive Macrophages in Survival Outcomes of Penile Squamous Cell Carcinoma
2026 · Adnan Fazili, Keerthi Gullapalli, et al. · Cancers · 1
PDF
A phase II study assessing the feasibility and clinical efficacy of adaptive immunotherapy combination with VEGFR-TKI in patients with advanced renal cell carcinoma
2026 · Firas Hatoum, Brandon Dyer, et al. · Future Oncology
Prognostic Role of PD-L1 in Penile Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
2026 · Nadine Mahmoud, Arfa Mustasam, et al. · Journal of the National Comprehensive Cancer Network
PDF
Evaluation of the Feasibility and Safety of Ifosfamide-Based Chemotherapy Regimens for Sarcomas in the Outpatient Setting
2026 · Mina Seo, Firas Hatoum, et al. · JCO Oncology Practice
Vaccine Therapy for the Management of Penile Cancer: Evidence, Opportunities and Challenges
2026 · Firas Hatoum, Ricardo Nehme, et al. · Vaccines
Transcriptomic profiling to identify cancer–immune meta-programs in penile squamous cell carcinoma.
2026 · Xuefeng Wang, Firas Hatoum, et al. · Journal of Clinical Oncology
Spatial immune architecture as used to define progression and treatment response in penile squamous cell carcinoma.
2026 · Firas Hatoum, Jin Xu, et al. · Journal of Clinical Oncology
Pembrolizumab plus high-dose IL-2 in advanced clear cell renal cell carcinoma: six-year survival outcomes and molecular signatures from a phase 2 trial
2026 · Jeffrey S. Johnson, Justin W. Miller, et al. · Nature Communications
Genitourinary Sarcomas
2026 · Luis G. Medina, Firas Hatoum, et al. · Surgical Oncology Clinics of North America
Single-cell transcriptomic characterization of NECTIN-4 expression in penile squamous cell carcinoma.
2026 · Jeffrey S. Johnson, Xiaoqing Yu, et al. · Journal of Clinical Oncology
PDF
Spatial and molecular determinants of response in penile squamous cell carcinoma.
2026 · Firas Hatoum, Jeffrey S. Johnson, et al. · Journal of Clinical Oncology
PDF
The prognostic role of PD-L1 in penile squamous cell carcinoma: A systematic review and meta-analysis.
2026 · Nadine Mahmoud, Arfa Mustasam, et al. · Journal of Clinical Oncology
PDF
Expansion and characterization of tumor-infiltrating lymphocytes from primary and metastatic immune checkpoint inhibitor-exposed renal cell carcinoma tumors.
2026 · Marine Potez, Justin Miller, et al. · Journal of Clinical Oncology
PDF
A multicenter, open-label, phase II study of adaptive combination immunotherapy with VEGFR-TKI for advanced renal cell carcinoma.
2026 · Justin Miller, Firas Hatoum, et al. · Journal of Clinical Oncology
PDF
Patient-reported outcomes in LITESPARK-005: a timely step toward patient-centered metrics in advanced renal cell carcinoma
2025 · Firas Hatoum, Brandon Dyer, et al. · Chinese Clinical Oncology
Evaluation of ifosfamide based chemotherapy regimens for sarcomas in the outpatient setting (IPOP): Cost savings and safety profile.
2025 · Firas Hatoum, Mina Seo, et al. · JCO Oncology Practice
PDF
Works count: 20
Citation count: 18
H-index: 3
I10-index:
Year
Topic
Type